TESTOZOLE- testosterone,usp pellet, implantable 
Advanced Pharmaceutical Technology, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Testozole 60mg/4mg

Indication:

Estrogen Receptor Positive Metastatic Breast Cancer

Usual Dosage:

180mg Testosterone & 12mg of Anastrozole

CAUTION:

Federal Law prohibits dispensing without prescription.

Storage:

Store t controlled room temperature

Manufactured by:

ADVANCED PHARMACEUTICAL TECHNOLOGY

Phone: (914)358-5260

Elmsford, NY 10523

Testozole (57377-060-01)

Testozole

Testozole

3 Sterile Pellets

For subcutaneous implantation

Each pellet contains:

60mg Testosterone

4mg Anastrozole

Caution:

Federal Law prohibits dispensing without presciption.

Store at controlled room temperature.

TESTOZOLE 
testosterone,usp pellet, implantable
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:57377-060
Route of AdministrationSUBCUTANEOUSDEA ScheduleCIII    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TESTOSTERONE (UNII: 3XMK78S47O) (TESTOSTERONE - UNII:3XMK78S47O) TESTOSTERONE60 mg
ANASTROZOLE (UNII: 2Z07MYW1AZ) (ANASTROZOLE - UNII:2Z07MYW1AZ) ANASTROZOLE4 mg
Inactive Ingredients
Ingredient NameStrength
POVIDONE (UNII: FZ989GH94E)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:57377-060-013 in 1 AMPULE; Type 0: Not a Combination Product01/01/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/01/2021
Labeler - Advanced Pharmaceutical Technology, Inc. (023237884)
Establishment
NameAddressID/FEIBusiness Operations
Advanced Pharmaceutical Technology, Inc.023237884manufacture(57377-060)

Revised: 5/2022
Document Id: e0056294-f01b-d902-e053-2a95a90ad711
Set id: d3c42530-07dd-8a7d-e053-2a95a90ab2b6
Version: 3
Effective Time: 20220527
 
Advanced Pharmaceutical Technology, Inc.